Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07149298 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital

Study acronym: CVCA
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: mcjimenezm to Instituto de Oftalmología Fundación Conde de Valencianav2 Show 5 more changesShow less
    • Primary endpoints revised (3)
    • Study completion date: Sep 2025 to Mar 2026
    • Study description revised
    • Study site revised
    • Collaborators shortened, about 7 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to evaluate both clinical changes and quality-of-life outcomes in patients with allergic conjunctivitis treated with allergen-specific immunotherapy, integrating objective clinical parameters and validated quality-of-life measures to obtain a comprehensive view of the therapeutic impact.
Trial Details
NCT Number NCT07149298
Lead Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Conditions
(from sponsor)		 Allergic Conjunctivitis of Both Eyes
Related terms Hypersensitivity
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov